Life Sciences

Determining Clinical Trial Feasibility With EHRs And EDC

patients-clinical-trials-ehr-edc

 

In an article from Clinical Leader, Chief Editor, Ed Miseta, and Bayer Healthcare’s VP Global Strategy & Development Advisor, Johann Proeve, discuss using electronic health record (EHR) and electronic data capture (EDC) systems to lower the overall costs of running clinical trials. 

Life Sciences - How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process

This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.

Get the Guide

By evaluating certain criteria against patient populations, EHR systems can help sponsors determine trial feasibility and shape better study protocols, reducing the number of amendments, which can cost anywhere from $300,000 to $500,000 each. EHR data could also dissuade sponsors from conducting certain trials, due the lack of specific patient populations. This in itself can prevent companies from having to initiate study start-up activities, including technology enablement, site training, and shipping products.

The article also shares how integrating an EHR system with an EDC solution can help reduce the need for manual data entry and verification.

You can read the article in its entirety here.

About the Author

Sr. Marketing Manager, Industries, Perficient

More from this Author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the Weekly Blog Digest:

Sign Up